^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    STK-009/SYNCAR-001

    i
    Other names: STK-009/SYNCAR-001, STK 009/SYNCAR 001, STK009/SYNCAR001
    Associations
    News
    Trials
    Company:
    Synthekine
    Drug class:
    CD19-targeted CAR-T immunotherapy, IL-2 stimulant
    Related drugs:
    Associations
    News
    Trials